Novel method developed can map surface protein complements on large numbers of individual exosomes. The findings of the study are published in the journal Nature Communications.
There is a growing demand for diagnostic markers for early disease detection and prognosis. Exosomes are potential biomarkers for cancer progression and neurodegenerative disease, but it can be difficult to identify what tissue a specific exosome comes from.
Cancer Immunotherapy
Cancer immunotherapy is a new advancement in cancer treatment that uses certain components of a person''s immune system to fight against cancer cells.
Advertisement
‘In order to use exosomes as biomarkers of diseases in various tissues, it is important to distinguish them according to their surface protein complements.’
Tweet it Now
Exosomes are released from all cells in the body. They convey protein and nucleic acid cargos between the cells as a form of intercellular communication, and they represent potential circulating biomarkers for tumor progression and metastasis, as well as for early detection of neurodegenerative disease.
In order to use exosomes as biomarkers of diseases in different tissues, it is vital to distinguish them according to their surface protein complements. Researchers at Uppsala University and Vesicode AB, along with collaborators, have developed a method that can map surface protein complements on large numbers of individual exosomes.
![Cancer Pain]( "Cancer Pain")
The novel proximity-dependent barcoding assay (PBA) reveals the surface protein composition of individual exosomes using antibody-DNA conjugates and next-generation sequencing. The method identifies proteins on individual exosomes using micrometer-sized, uniquely tagged single-stranded DNA clusters generated by rolling circle amplification.
"This technology will not only benefit researchers studying exosomes but also enable high-throughput biomarker discovery. We will further develop and validate the PBA technology and provide service to researchers starting later this year. We believe single exosome analysis will allow this exciting class of biomarkers to reach its full potential," says Di Wu, researcher, and inventor of the PBA technology and founder of Vesicode AB, commercializing the technique.
"This new technology will allow large-scale screens for biomarkers in disease, complementing a panel of methods for sensitive and specific detection of exosomes that we have previously established," says Masood Kamali-Moghaddam one of the group leaders at the Molecular Tools unit at Uppsala University.
Source: Eurekalert
Advertisement
The novel proximity-dependent barcoding assay (PBA) reveals the surface protein composition of individual exosomes using antibody-DNA conjugates and next-generation sequencing. The method identifies proteins on individual exosomes using micrometer-sized, uniquely tagged single-stranded DNA clusters generated by rolling circle amplification.
"This technology will not only benefit researchers studying exosomes but also enable high-throughput biomarker discovery. We will further develop and validate the PBA technology and provide service to researchers starting later this year. We believe single exosome analysis will allow this exciting class of biomarkers to reach its full potential," says Di Wu, researcher, and inventor of the PBA technology and founder of Vesicode AB, commercializing the technique.
"This new technology will allow large-scale screens for biomarkers in disease, complementing a panel of methods for sensitive and specific detection of exosomes that we have previously established," says Masood Kamali-Moghaddam one of the group leaders at the Molecular Tools unit at Uppsala University.
Source: Eurekalert
Alzheimers Disease
Alzheimer''s disease is a progressive neurodegenerative disease affecting memory and thinking and making the person increasingly dependent on others.
Advertisement
 New Antibody Test to Detect Proteins Implicated in Neurodegenerative ConditionsThe antibody that binds to the tau-proteins, acts like a magnifying glass, amplifying tau levels so that differences between individuals could be seen more easily. | Advertisement
|
Advertisement
Latest Research News
Reducing the production of Snail post-brain injury leads to heightened inflammation and amplified cell mortality.
For individuals with inflammatory bowel disease (IBD), the routine act of eating and nutrient absorption can vary significantly.
Painful realities of racial discrimination and bias are increasingly acknowledged as harmful to the well-being.
Role of flaxseed in the relationship between gut microorganisms and mammary gland microRNAs has been uncovered by a new study.
New mRNA stem cell therapy, akin to COVID-19 vaccine tech, shows potential against chronic and acute liver diseases.